OptimizeRx OPRX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's common stock, shares authorized (in shares)?
- OptimizeRx (OPRX) reported common stock, shares authorized (in shares) of $166.67M in Q1 2026.
- How has OptimizeRx's common stock, shares authorized (in shares) changed year-over-year?
- OptimizeRx's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $166.67M to $166.67M.
- What is the long-term trend for OptimizeRx's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), OptimizeRx's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $166.67M to $166.67M.